NCT00428350 - Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Schizophrenia

Interventions

DRUG

Quetiapine Fumarate (Seroquel)

Trial Locations (9)

Research Site, Guangzhou

Research Site, Harbin

Research SIte, Wuhan

Research Site, Nanjing

Research Site, Jinan

Research Site, Kunming

Research Site, Hangzhou

Research Site, Huzhou

Research Site, Beijing